Background: Pediatric cancer is the prevailing cause of death among children over one year in the Western world. Studies show promising results with probiotic agents inhibiting cancer cells. Objectives: This project aimed to experimentally evaluate the anti-cancer activity of the probiotic product LaBiNIC® through two questions: 1) Would cell-free supernatant of LaBiNIC® bacterial culture decrease ...